Novo Nordisk(GB:0TDD)
$40.820.00 (0.00%)
GB:0TDD
Novo Nordisk financials statements
$40.82
At close:0.00 (0.00%)
Novo Nordisk (0TDD) Income Statement
11 Followers
Novo Nordisk Income Statement
Last quarter (Q3 2026), Novo Nordisk's total revenue was kr79.19B, an increase of 5.63% from the same quarter last year. In Q3, Novo Nordisk's net income was kr16.74B. See Novo Nordisk’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 309.06B | kr 290.40B | kr 232.26B | kr 176.95B | kr 140.80B | |
| kr 250.28B | kr 245.88B | kr 196.50B | kr 148.51B | kr 117.14B | |
| kr 122.62B | kr 117.54B | kr 93.92B | kr 73.70B | kr 58.50B | |
| Depreciation and Amortization | kr 21.98B | kr 19.11B | kr 9.41B | kr 7.36B | kr 6.03B |
| kr 156.73B | kr 147.94B | kr 114.63B | kr 76.80B | kr 65.39B | |
| kr 127.66B | kr 128.34B | kr 102.57B | kr 74.81B | kr 58.64B | |
| kr 2.88B | kr -1.15B | kr 2.10B | kr -5.75B | kr 436.00M | |
| kr 130.54B | kr 127.19B | kr 104.67B | kr 69.06B | kr 59.08B | |
| kr 102.43B | kr 100.99B | kr 83.68B | kr 55.52B | kr 47.76B | |
| Per Share Metrics | |||||
| Basic EPS | kr 23.06 | kr 22.67 | kr 18.67 | kr 12.26 | kr 10.40 |
| Diluted EPS | kr 23.03 | kr 22.63 | kr 18.62 | kr 12.22 | kr 10.37 |
| Weighted Average Shares Outstanding | 4.45B | 4.45B | 4.48B | 4.53B | 4.59B |
| Weighted Average Shares Outstanding (Diluted) | 4.45B | 4.46B | 4.49B | 4.54B | 4.61B |
Currency in DKK
